Cardiovascular disease (CVD) remains the second leading cause of death in North America. Metabolic syndrome (MetS) is a risk factor for CVD and renal damage. Early detection and reduction of risk factors before the disease progresses is imperative. Doctor’s Data offers comprehensive profiles for reducing risk, which include evaluation of 16 primary and secondary risk factors, focused biomarkers including oxidized LDL, PLAC® and Glycomark® to support early detection and targeted treatment.

Compare Cardiometabolic Profiles